T cell exhaustion: from pathophysiological basics to tumor immunotherapy K Catakovic, E Klieser, D Neureiter, R Geisberger Cell Communication and Signaling 15, 1-16, 2017 | 180 | 2017 |
TIGIT expressing CD4+ T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia K Catakovic, FJ Gassner, C Ratswohl, N Zaborsky, S Rebhandl, ... Oncoimmunology 7 (1), e1371399, 2018 | 78 | 2018 |
Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL 1 transgenic mouse model FJ Gassner, N Zaborsky, K Catakovic, S Rebhandl, M Huemer, A Egle, ... British journal of haematology 170 (4), 515-522, 2015 | 52 | 2015 |
Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia FJ Gassner, N Zaborsky, D Neureiter, M Huemer, T Melchardt, A Egle, ... Haematologica 99 (5), 67, 2014 | 44 | 2014 |
APOBEC3 signature mutations in chronic lymphocytic leukemia S Rebhandl, M Huemer, FJ Gassner, N Zaborsky, D Hebenstreit, ... Leukemia 28 (9), 1929-1932, 2014 | 34 | 2014 |
Imprecision and DNA break repair biased towards incompatible end joining in leukemia FJ Gassner, M Schubert, S Rebhandl, K Spandl, N Zaborsky, K Catakovic, ... Molecular Cancer Research 16 (3), 428-438, 2018 | 15 | 2018 |
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the … A Egle, M Steurer, T Melchardt, L Weiss, FJ Gassner, N Zaborsky, ... Annals of Hematology 97, 1825-1839, 2018 | 11 | 2018 |
Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia S Rebhandl, M Huemer, N Zaborsky, FJ Gassner, K Catakovic, TK Felder, ... European Journal of Immunology 44 (7), 2175-2187, 2014 | 10 | 2014 |
Evidence for non-cancer-specific T cell exhaustion in the Tcl1 mouse model for chronic lymphocytic leukemia T Parigger, FJ Gassner, C Scherhäufl, AA Bakar, JP Höpner, A Hödlmoser, ... International Journal of Molecular Sciences 22 (13), 6648, 2021 | 4 | 2021 |
TIGIT as a new target for checkpoint inhibition for chronic lymphocytic leukemia K Catakovic, FJ Gassner, C Rathswohl, R Greil, T Hartmann, ... LEUKEMIA & LYMPHOMA 58, 53-54, 2017 | | 2017 |